Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study.
COVID-19
epidemiology
general medicine (see internal medicine)
infectious diseases
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
23 03 2021
23 03 2021
Historique:
entrez:
24
3
2021
pubmed:
25
3
2021
medline:
30
3
2021
Statut:
epublish
Résumé
Identify predictors of clinical deterioration in a virtual hospital (VH) setting for COVID-19. Real-world prospective observational study. VH remote assessment service in West Hertfordshire NHS Trust, UK. Patients with suspected COVID-19 illness enrolled directly from the community (postaccident and emergency (A&E) or medical intake assessment) or postinpatient admission. Death or (re-)admission to inpatient hospital care during VH follow-up and for 2 weeks post-VH discharge. 900 patients with a clinical diagnosis of COVID-19 (455 referred from A&E or medical intake and 445 postinpatient) were included in the analysis. 76 (8.4%) of these experienced clinical deterioration (15 deaths in admitted patients, 3 deaths in patients not admitted and 58 additional inpatient admissions). Predictors of clinical deterioration were increase in age (OR 1.04 (95% CI 1.02 to 1.06) per year of age), history of cancer (OR 2.87 (95% CI 1.41 to 5.82)), history of mental health problems (OR 1.76 (95% CI 1.02 to 3.04)), severely impaired renal function (OR for eGFR <30=9.09 (95% CI 2.01 to 41.09)) and having a positive SARS-CoV-2 PCR result (OR 2.0 (95% CI 1.11 to 3.60)). These predictors may help direct intensity of monitoring for patients with suspected or confirmed COVID-19 who are being remotely monitored by primary or secondary care services. Further research is needed to confirm our findings and identify the reasons for increased risk of clinical deterioration associated with cancer and mental health problems.
Identifiants
pubmed: 33757955
pii: bmjopen-2020-045356
doi: 10.1136/bmjopen-2020-045356
pmc: PMC7992373
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e045356Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
J Clin Virol. 2020 Jul;128:104431
pubmed: 32442756
BMJ. 2020 Jun 4;369:m2119
pubmed: 32499317
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
J Med Virol. 2020 Oct;92(10):2188-2192
pubmed: 32436996
Stat Med. 2019 Mar 30;38(7):1276-1296
pubmed: 30357870
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Am J Prev Med. 2009 Apr;36(4):341-50
pubmed: 19285199
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Ann Oncol. 2020 Aug;31(8):1088-1089
pubmed: 32330541
Clin Infect Dis. 2020 Jul 28;71(15):833-840
pubmed: 32296824
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328